Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
      Description

      This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL).

      Conditions
      T-cell LymphomaCutaneous/Peripheral T-Cell LymphomaPeripheral T-cell LymphomaPeripheral T-Cell Lymphoma, Not ClassifiedPrimary Cutaneous T-cell LymphomaCutaneous T-Cell Lymphoma, UnspecifiedCutaneous T-cell LymphomaFollicular T-Cell LymphomaAngioimmunoblastic T-cell LymphomaSézary's DiseaseMycosis Fungoides
      Talk to us